The company has already started investments in the Iasi industrial platform, opened a cream, gel production unit, installed photovoltaic panels and its representatives are seeking further growth possibilities. The plan has already been set, but the company’s strategy is adjusting to new opportunities.
Funding sources are multiple and include both state aid from the finance ministry, a loan from the European Investment Bank, as well as own sources.
Human resources are also included in the investment chapter. As a matter of fact, Antibiotice Iasi is the biggest employer in the local drug production, with over 1,350 people in its team.
Antibiotice Iasi went beyond RON600 million turnover in 2023, up 7%, and doubled its profit, to RON81 million.
For 2024, it targets RON700 million turnover and over RON100 million profit.
(English version by Catalina Apostoiu)